Patrick Darby - Encompass Health President
| EHC Stock | USD 102.94 0.10 0.1% |
President
Mr. Patrick Darby is Executive Vice President, General Counsel, Secretary of HealthSouth Corporationrationration. Before joining us, Mr. Darby was a partner of the law firm Bradley Arant Boult Cummings LLP in Birmingham, Alabama, where he practiced from 1990 to 2016, and an adjunct professor at Cumberland School of Law, in Birmingham, Alabama. He is a member of the Birmingham Bar Association, Alabama State Bar, and American Bar Association. since 2016.
| Age | 56 |
| Tenure | 8 years |
| Address | 9001 Liberty Parkway, Birmingham, AL, United States, 35242 |
| Phone | 205 967 7116 |
| Web | https://www.encompasshealth.com |
Encompass Health Management Efficiency
The company has Return on Asset of 0.0838 % which means that on every $100 spent on assets, it made $0.0838 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2292 %, implying that it generated $0.2292 on every 100 dollars invested. Encompass Health's management efficiency ratios could be used to measure how well Encompass Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.22, whereas Return On Tangible Assets are forecasted to decline to 0.05. At present, Encompass Health's Deferred Long Term Asset Charges is projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.46, whereas Total Assets are forecasted to decline to about 3.8 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Sean Gaffney | Addus HomeCare | 44 | |
| Zheng Cheng | Concord Medical Services | 57 | |
| Jeffrey Smith | National HealthCare | 61 | |
| Michael Scarbrough | InnovAge Holding Corp | N/A | |
| Brian Kidd | National HealthCare | 49 | |
| Martin Jackson | Select Medical Holdings | 69 | |
| Bradley Bickham | Addus HomeCare | 61 | |
| Brian Poff | Addus HomeCare | 50 | |
| Scott Romberger | Select Medical Holdings | 63 | |
| B Flatt | National HealthCare | 57 | |
| John Hollinsworth | Acadia Healthcare | 60 | |
| Thomas Mullin | Select Medical Holdings | 40 | |
| Anne Bailey | ModivCare | 51 | |
| Leroy McIntosh | National HealthCare | 63 | |
| Josh McCreary | National HealthCare | 51 | |
| John Saich | Select Medical Holdings | 55 | |
| Brian Wayment | Pennant Group | N/A | |
| Faisal Khan | ModivCare | N/A | |
| Michael Ussery | National HealthCare | 65 | |
| Spencer Burton | The Ensign Group | 45 | |
| Ilias Simpson | ModivCare | 40 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0838 |
Encompass Health Corp Leadership Team
Elected by the shareholders, the Encompass Health's board of directors comprises two types of representatives: Encompass Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encompass. The board's role is to monitor Encompass Health's management team and ensure that shareholders' interests are well served. Encompass Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encompass Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Reidy, Independent Director | ||
| John Darby, General VP | ||
| Jerry Gray, President Region | ||
| John Chidsey, Independent Director | ||
| Nancy Schlichting, Independent Director | ||
| Yvonne Curl, Independent Director | ||
| Leo Higdon, Non-Executive Independent Chairman of the Board | ||
| Andrew Price, Chief Accounting Officer | ||
| Mark Tarr, President, Chief Executive Officer, Director | ||
| Gregory Carmichael, Independent Director | ||
| Anthony Hernandez, Chief Human Resource Officer | ||
| Kevin Connor, Independent Director | ||
| Dawn Rock, Chief Officer | ||
| Linda Wilder, President Region | ||
| Elissa Charbonneau, Chief Medical Officer | ||
| Edmund Fay, Senior Vice President Treasurer | ||
| Joan Herman, Independent Director | ||
| Patricia Maryland, Independent Director | ||
| Charles Elson, Independent Director | ||
| L Shaw, Independent Director | ||
| Melanie Lewis, Senior Vice President Chief Business Development Officer | ||
| Peter Mantegazza, President Region | ||
| MS DO, Chief Officer | ||
| Mark Miller, Senior Vice President of Investor Relations | ||
| Terrance Williams, Independent Director | ||
| April Anthony, Chief Executive Officer and President - Encompass | ||
| Patrick Darby, Executive Vice President General Counsel, Secretary | ||
| Barbara Jacobsmeyer, Executive Vice President and President - Inpatient Hospitals | ||
| Frank Brown, President Region | ||
| Leslye Katz, Independent Director | ||
| Rusty Yeager, Chief VP | ||
| Donald Correll, Independent Director | ||
| John Maupin, Independent Director | ||
| Douglas Coltharp, Chief Financial Officer, Executive Vice President |
Encompass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Encompass Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0838 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 13.02 B | ||||
| Shares Outstanding | 100.75 M | ||||
| Shares Owned By Insiders | 1.36 % | ||||
| Shares Owned By Institutions | 98.16 % | ||||
| Number Of Shares Shorted | 1.1 M | ||||
| Price To Earning | 18.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.26 | Dividend Share 0.62 | Earnings Share 4.25 | Revenue Per Share 52.255 | Quarterly Revenue Growth 0.119 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.